#Ireland #biotechnology #CoreFX #County Cork

CoreFX Ingredients Establishes European Innovation Hub in Ireland

CoreFX Ingredients LLC, a leading player in the biotechnology sector, has made a strategic move to broaden its global presence by setting up a new European innovation headquarters in County Cork, Ireland. This development is backed by Enterprise Ireland and signifies a significant step in CoreFX's commitment to advancing nutritional performance through its groundbreaking CoreNhanced™ platform.

The establishment of CoreNhanced Biotechnology Limited marks an important milestone in CoreFX's trajectory, positioning Ireland as a central hub for research and commercial expansion across Europe. The new facility will act as a catalyst for accelerating technological advancements that improve the performance of bioactive molecules during manufacturing and throughout their shelf life.

One of the driving factors behind choosing Ireland is its exceptional reputation in food science, biotechnology, and collaborative research. With its well-established innovation ecosystem and access to top-tier scientific talent, Ireland offers an ideal environment for CoreFX to realize its ambitions. The collaboration with Teagasc Moorepark is particularly noteworthy, as it leverages one of Europe's most advanced centers for innovation in food science.

Denis Neville, Founder and CEO of CoreFX, expressed the personal significance of returning to Ireland to establish the headquarters. He emphasized the importance of this decision, not just for personal reasons but also for the company’s strategic vision. “By merging the scientific expertise of Teagasc Moorepark with the support provided by Enterprise Ireland, we are establishing an innovation platform that will speed up the transition of state-of-the-art nutritional technologies from research phases to commercial applications,” he stated.

The launch of this new operation has started promisingly with a skilled team already in place. It will initially include three scientists spearheaded by Dr. Cara Maloney, a renowned expert in drug delivery and biomaterials. Dr. Maloney’s extensive background in formulation development and analytical methods, coupled with her numerous peer-reviewed publications, underpins CoreFX's dedication to innovation and scientific excellence.

Trevor Dunne has taken up the mantle of Managing Director for Europe, bringing a wealth of experience spanning over two decades in the food, flavor, and nutrition industries. His role will focus on enhancing commercial growth and forming partnerships throughout the European market.

Enterprise Ireland has been a crucial ally for CoreFX since 2023, providing vital support for the company’s European strategy and fostering research collaborations. Mark Christal, Executive Director of Enterprise Ireland, commended CoreFX’s efforts, reflecting on how this new headquarters represents a pivotal chapter in the company’s growth journey and a strong endorsement of Ireland’s dynamic food science and biotechnology landscape.

As CoreFX strides forward, it aims not only to enhance its own operational prowess but also contribute significantly to the nutritional landscape in Europe and beyond. With a commitment to turning pioneering scientific research into tangible health and wellness products, CoreFX is set to redefine the standards within the biotechnology industry, driving innovations that cater to the evolving needs of consumers worldwide.

For more details about CoreFX and its initiatives, visit their official website.